A comparative study of anti-ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura.
Maria Rita CozziFabio Del BenChiara CorsoAgostino Steffan
Published in: Research and practice in thrombosis and haemostasis (2024)
While CLIA and ELISA might be interchangeable for assessing ADAMTS-13 activity, they are not equivalent for detecting AAbs, particularly in patients in clinical remission with ADAMTS-13 activity between 10% and 50%.